Clinical trials in Soest

Current clinical trials focus on metastatic breast cancer treatment optimization, specifically studying HR-positive, HER2-negative variants. Research explores the effectiveness of therapy discontinuation protocols and long-term disease control strategies.

• CDK4/6 Inhibitor Studies
• Treatment Discontinuation Protocols
• Disease Stabilization Assessment

Investigations include comprehensive analysis of treatment response patterns and survival outcomes in advanced breast cancer patients receiving targeted therapies.

Research initiatives examine treatment efficacy patterns in advanced breast cancer, with particular attention to first-line therapeutic interventions. Studies evaluate temporal and molecular patterns of treatment response.

• Progression-Free Survival Analysis
• Overall Survival Assessment
• Treatment Response Patterns

These trials aim to enhance understanding of treatment resistance and improve patient outcomes through targeted therapeutic approaches.